skip to Main Content

Cancer Services

Breast Cancer

Radiation Oncology clinical trials

Name: EXPERT

A randomised phase III trial of adjuvant radiation therapy versus observation following breast conserving surgery and endocrine therapy in patients with molecularly characterised luminal A early breast cancer (EXPERT)

Principal Investigator: Dr Hester Lieng
Study Coordinator: Richard Clayton
Status: Recruiting
Condition: Breast Cancer
External page link More Information about EXPERT

Medical Oncology Clinical Trials

Name: GLORIA

A Phase 3, Randomized, Open-Label Study of the Anti-Globo H Vaccine Adagloxad Simolenin (OBI-822)/OBI-821 in the Adjuvant Treatment of Patients with High Risk, Early Stage Globo H-Positive Triple Negative Breast Cancer.

Principal Investigator: Dr Susan Tiley
Study Coordinator: Cassandra Rubio
Status: Recruiting
Condition: Breast Cancer
External page link More information about GLORIA study

Name: FINER

A double-blind placebo controlled randomised phase III trial of Fulvestrant and Ipatasertib as treatment for advanced HER-2 negative and Estrogen receptor positive (ER+) breast cancer following progression on first line CDK 4/6 inhibitor and aromatase inhibitor.

Principal Investigator: Dr Susan Tiley
Study Coordinator: Bronwyn Raymond
Status: Recruiting
Condition: Breast Cancer
External page link More information about FINER

Name: DECRESCENDO

De-escalation of adjuvant chemotherapy in HER2+, Estrogen receptor-negative, node-neg early breast cancer patients who achieved pathological complete response after neoadjuvant chemotherapy and dual HER2 blockade.

Principal Investigator: Dr Susan Tiley
Study Coordinator: Michelle Dixon
Status: Recruiting
Condition: Breast Cancer
External page link More information about DECRESCENDO

Name: EMBER-4

A Randomized, Open-Label, Phase 3 Study of Adjuvant Imlunestrant vs Standard Adjuvant Endocrine Therapy in Patients who have Previously Received 2 to 5 years of Adjuvant Endocrine Therapy for ER+, HER2- Early Breast Cancer with an Increased Risk of Recurrence

Principal Investigator: Dr Susan Tiley
Study Coordinator: Maree Jarrett
Status: Recruiting
Condition: Breast Cancer
External page link More information about EMBER-4

More information

For more information about medical oncology clinical trials, please contact the Nurse Unit Manager on 02 4320 9890 or see:

Internal page Research and Clinical Trials

Back To Top